Recruiting
Phase 2

Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

Sponsor:

Emory University

Code:

NCT05103904

Conditions

Recurrent Hepatocellular Carcinoma

Stage III Hepatocellular Carcinoma AJCC v8

Stage IIIA Hepatocellular Carcinoma AJCC v8

Stage IIIB Hepatocellular Carcinoma AJCC v8

Stage IV Hepatocellular Carcinoma AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Laboratory Biomarker Analysis

Lenvatinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information